Skip to main content
Clinical Trials/NCT07222722
NCT07222722RecruitingNot Applicable

Near Infrared Spectroscopy (NIRS) Monitoring as an Early Predictor of Acute Kidney Injury (AKI) in a Vulnerable Neonatal Intensive Care Unit (NICU) Population

NYU Langone Health1 site in 1 country100 target enrollmentStarted: November 1, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
100
Locations
1
Primary Endpoint
Average NIRS Value (SrSO2)

Study Overview

Brief Summary

The primary objective of this study is to describe the pattern of renal tissue oxygen saturation (SrSO2) using near-infrared spectroscopy (NIRS) in premature infants <30 weeks gestational age. The secondary objective of this study is to evaluate prenatal and postnatal risk factors for acute kidney injury (AKI) in premature infants <30 weeks gestational age. The investigators will also compare various rates of complications including death, length-of-stay, and prolonged duration of mechanical ventilation, among others.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
24 Weeks to 30 Weeks (Child)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Any neonate less than 30 weeks in gestational age
  • •Willingness and capacity of both adult parents/guardians to sign consent

Exclusion Criteria

  • •An infant with known congenital anomalies of the kidney (i.e., grade 4 or 5 vesicoureteral reflux (VUR), posterior urethral valves, moderate or severe hydronephrosis, autosomal recessive polycystic kidney disease (ARPKD), bilateral renal agenesis or dysplasia)
  • •Age >30 weeks gestational age
  • •Age <24 weeks and <500 grams (will be excluded due to sensitivity of skin in this vulnerable population).
  • •Clinician's decision that NIRS is not suitable due to the patient's clinical condition

Arms & Interventions

NICU patients born less than 30 weeks gestational age

Experimental

All patients included in the study will be assigned to receive NIRS monitoring.

Intervention: NIRS Monitoring (Device)

Outcomes

Primary Outcomes

Average NIRS Value (SrSO2)

Time Frame: Up to Day-of-life 7

NIRS values measured as renal tissue oxygen saturation (SrSO2); measured continuously over first 7 days of life.

Secondary Outcomes

  • Duration of Mechanical Ventilation(Up to Day of NICU Discharge (Approximately Day-of-life 7; subject to large individual variations))
  • Serum Creatinine Values(Day-of-life 1, Day-of-life 3, Day-of-life 7, Day-of-life 14)
  • Average Urine Output(Up to Day of NICU Discharge (Approximately Day-of-life 7; subject to large individual variations))
  • Length-of-Stay in NICU(Day of NICU Discharge (Approximately Day-of-life 7; subject to large individual variations))
  • Duration of Non-Invasive Ventilation(Up to Day of NICU Discharge (Approximately Day-of-life 7; subject to large individual variations))

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

NIRS Monitoring in the NICU and AKI | Clinical Trial